Cizzle Biotechnology Holdings Plc
Status: Publicly traded
Direct answer
Cizzle Biotechnology Holdings Plc is publicly traded on LSE under the ticker CIZ.L.
Cizzle Biotechnology Holdings Plc specializes in developing an advanced immunoassay diagnostic test. This innovative tool aims to identify the CIZ1B biomarker, facilitating the early detection of lung cancer. The company, previously known as Cizzle Biotechnology Limited, officially changed its corporate identity to Cizzle Biotechnology Holdings Plc in May 2021. Its main operational base is situated in London, United...
Can you invest in Cizzle Biotechnology Holdings Plc?
Yes. Cizzle Biotechnology Holdings Plc is publicly traded on LSE under the ticker CIZ.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cizzle Biotechnology Holdings Plc
Detailed equity research is provided by MarketSnap.